VivoSeq
Infectious Disease

Cholera

1

Pipeline Programs↗

1

Active Trials↗

0

Companies Involved↗

Cholera is an early-stage landscape with 1 program across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Pipeline

Programs by Phase

Preclinical1

Cholvax

International Centre for Diarrhoeal Disease Research, Bangladesh

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

4

clinical trials

Completed3 · 75%
Recruiting1 · 25%

Clinical Trials

Trial Activity

Cholera Toxin B Subunit (CTB) Administered by Mucosal Way in Healthy Adult Volunteer
Completed·—·Phase 1·NCT00820144·40 enrolled
Zinc Supplementation in Cholera Patients
Completed·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 3·NCT00226616
PK Study of iOWH032 in Adult Male/Female Healthy Volunteers & Adult Males With Cholera
Completed·PPATH·Phase 1·NCT01823939·26 enrolled
Case-area Targeted Interventions (CATIs) Among Household Contacts and Neighbouring Households After Defining Cholera Hotspot Areas in Bangladesh: The Effectiveness of OCV and Potential Impact on Cholera Control
Recruiting·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Preclinical·NCT07685574·68,400 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)